AI Article Synopsis

  • Heart failure is a major health issue that's expected to grow as the population ages, leading to more cases of morbidity and mortality.
  • Left ventricular assist devices (LVADs) are playing a crucial role in treating advanced heart failure, with over 5,000 implants done annually, making them the most widely used durable support devices globally.
  • The article focuses on the intensive care management practices for patients with LVADs right after they receive the device, highlighting important considerations during the early post-implantation period.

Article Abstract

Heart failure is a leading cause of morbidity and mortality, the incidence of which is predicted to continue to increase as the population ages. Left ventricular assist devices (LVADs) in particular have emerged as important therapies for the support of patients with advanced heart failure needing short- or long-term mechanical circulatory support. With over 5000 implantations per year, LVADs are the most commonly used durable devices worldwide. In this article, we provide an overview of the intensive care management of patients with LVADs during the early post-implantation period.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386988PMC
http://dx.doi.org/10.1007/s12055-022-01434-yDOI Listing

Publication Analysis

Top Keywords

left ventricular
8
ventricular assist
8
heart failure
8
postoperative care
4
care left
4
assist device
4
device implantation
4
implantation considerations
4
considerations cardiac
4
cardiac surgical
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!